179 results on '"Bradley, John"'
Search Results
2. Bacteriophage Therapy of Multidrug-resistant Achromobacter in an 11-Year-old Boy With Cystic Fibrosis Assessed by Metagenome Analysis.
3. Safety and Efficacy of Ceftolozane/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial
4. In vitro Activity of Ceftaroline Against an International Collection of Kingella kingae Isolates Recovered From Carriers and Invasive Infections
5. In vitro Activity of Ceftaroline Against an International Collection of Kingella kingae Isolates Recovered From Carriers and Invasive Infections.
6. Pediatric Osteoarticular Infections Caused by Mycobacteria Tuberculosis Complex
7. Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia.
8. Cerebrospinal Fluid Shunt Infections: A Multicenter Pediatric Study.
9. Pediatric Osteoarticular Infections Caused by Mycobacteria Tuberculosis Complex: A 26-Year Review of Cases in San Diego, CA.
10. Pharmacokinetics and Safety of Single-dose Tedizolid Phosphate in Children 2 to <12 Years of Age
11. An 11-Year-old Male With X-linked Agammaglobulinemia and Persistent Abdominal Pain
12. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections
13. Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis
14. Frequency of Dosing of Cephalexin for Oral Step-Down Therapy of Pediatric Osteoarticular Infections Caused by Methicillin-Sensitive Staphylococcus Aureus
15. Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis
16. Safety and Efficacy of Ceftazidime–Avibactam in the Treatment of Children ≥3 Months to <18 Years With Complicated Urinary Tract Infection: Results from a Phase 2 Randomized, Controlled Trial
17. Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial
18. Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection
19. Safety and Efficacy of Oral and/or Intravenous Tedizolid Phosphate From a Randomized Phase 3 Trial in Adolescents With Acute Bacterial Skin and Skin Structure Infections.
20. Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control Study.
21. Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia
22. Multimodal Treatment of Rhinocerebral Mucormycosis in a Pediatric Patient With Relapsed Pre-B Acute Lymphoblastic Leukemia
23. An Observational Study of Severe Pertussis in 100 Infants ≤120 Days of Age
24. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post–Pneumococcal Conjugate Vaccine Era
25. Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age
26. A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection
27. A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia
28. Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure
29. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone
30. Safety and Tolerability of Doripenem in Hospitalized Children With Complicated Intra-Abdominal Infection, Complicated Urinary Tract Infections and Pneumonia
31. Pharmacokinetics, Safety and Tolerability of Single Dose Dalbavancin in Children 12–17 Years of Age
32. Single-dose Pharmacokinetics of Daptomycin in Pediatric Patients 3–24 Months of Age
33. Exchange Blood Transfusion in the Management of Severe Pertussis in Young Infants
34. Improved Vancomycin Dosing in Children Using Area Under the Curve Exposure
35. Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
36. Editor’s Note
37. Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents.
38. Transmission of Meropenem in Breast Milk
39. Persistent Subcutaneous Nodule
40. Single-dose Pharmacokinetics and Tolerability of Daptomycin 8 to 10 mg/kg in Children Aged 2 to 6 Years With Suspected or Proved Gram-positive Infections
41. Prevalence of Hepatitis C Virus Antibody in Newborn Infants in Southern California in 2003
42. Pharmacokinetics, Pharmacodynamics, and Monte Carlo Simulation
43. Safety of Oseltamivir Compared With the Adamantanes in Children Less Than 12 Months of Age
44. Meropenem Pharmacokinetics, Pharmacodynamics, and Monte Carlo Simulation in the Neonate
45. Comparative Study of Levofloxacin in the Treatment of Children With Community-Acquired Pneumonia
46. Comparative Safety Profile of Levofloxacin in 2523 Children With a Focus on Four Specific Musculoskeletal Disorders
47. Recurrent Systemic Pneumococcal Disease in Children
48. COMMENTARY: Antibiotic Stewardship in Pediatrics: A Necessity
49. COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS NECROTIZING FASCIITIS IN A NEONATE
50. Prediction of Neurologic Sequelae in Childhood Tuberculous Meningitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.